Choices & Changes Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 155 Diplomat Dr, Suite C, Columbia City, IN 46725 Phone: 260-244-0264 Fax: 260-244-1983 |
Somebody Cares Inc Poetry Therapist Medicare: Not Enrolled in Medicare Practice Location: 333 N Oak St, Suite K, Columbia City, IN 46725 Phone: 260-244-3427 Fax: 260-244-3427 |
Andrew Ott Community/Behavioral Health Agency Medicare: Medicare Enrolled Practice Location: 402 N. Washington St., Columbia City, IN 46725 Phone: 260-244-7413 Fax: 260-387-6984 |
Live Heal Grow Counseling Services Counselor Medicare: Medicare Enrolled Practice Location: 360 N Oak St, Columbia City, IN 46725 Phone: 260-244-0264 Fax: 260-244-1983 |
Jt Counseling Group, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 3558 N Airport Rd, Columbia City, IN 46725 Phone: 260-229-2141 |
News Archive
"As two people who worked as physicians in the early years of the HIV/AIDS epidemic before the miracle of antiretroviral drug (ARV) therapy, and who now have the honor of leading the domestic and global HIV/AIDS programs for the Obama administration, we look back in awe of the American leadership that has transformed the epidemic in the 22 years since the International AIDS Conference was last held on U.S. soil," Grant Colfax, director of the Office of National AIDS Policy, and U.S. Global AIDS Coordinator Ambassador Eric Goosby write in a Washington Blade opinion piece.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).
An international team of investigators from centers in the United States and the United Kingdom, including Weill Cornell Medical College, have been awarded a grant for $10 million over a three-year period to study the molecular underpinnings of metastatic prostate cancer while creating a comprehensive testing system to optimize personalized treatments.
Vitamin Shoppe, Inc. today announced that the public offering of 6,236,320 shares of its common stock has priced at $23.50 per share. All of the shares of common stock are being sold by certain stockholders of Vitamin Shoppe. The underwriters have a 30-day option to purchase up to an additional 935,448 shares from the selling stockholders.
Nonin Medical, Inc. announced today the publication of two separate studies that demonstrate the clinical efficacy of the company's EQUANOX Model 7600 Cerebral and Somatic Oximetry System in adult and pediatric patients.
› Verified 4 days ago